Benzinga's M&A Chatter for Wednesday April 3, 2013

The following are the M&A deals, rumors and chatter circulating on Wall Street for Wednesday April 3, 2013: Valeant Raises Bid for Obagi Medical Products to $24.00/Share In Cash The Offer: Valeant Pharmaceuticals (NYSE: VRX ) announced Wednesday that Valeant and Obagi Medical Products (NASDAQ: OMPI ) have executed an